19 April 2017 in Journal of Obstetrics and Gynaecology Research
17 January 2017 in The Journal of Maternal-Fetal & Neonatal Medicine
Objective: Evidence supports the need of dose-adjustment of several drugs according to body mass index (BMI) to prevent toxicity in the underweight, and ensure efficacy in obese women. However, for MgSO4 neuroprotection, the effect of BMI on maternal toxicity and fetal neuroprotection is understudied. We analyze the effect of BMI on maternal/infant outcomes after MgSO4. Methods: Secondary analysis of a clinical trial that studied MgSO4 neuroprotection. Maternal side effects, magnesium cord levels, and offspring cerebral palsy/death were analyzed along BMI strata using ANOVA and chi-square test. Logistic regression was used to calculate adjusted odds ratios according to the treatment and BMI, using nonobese that received placebo as reference. Interaction analyses were performed to validate differential efficacy of BMI. Results: From 2241 women, more side effects and higher magnesium cord levels were seen in underweight women (p = 0.05). MgSO4 neuroprotection was effective in the non-obese (p = 0.02), but not in obese women (p = 1.00). In multivariate analyses, MgSO4 significantly reduced cerebral palsy only in nonobese women. Interaction analyses showed the moderator effect of BMI (p = 0.169). Increasing MgSO4 dose in obese mothers may ensure neuroprotective efficacy without representing increased maternal risks. Considering costs of studying this association, current analysis may form the basis for reasonable practice.
21 November 2015 in Archives of Gynecology and Obstetrics
25 May 2015 in The Journal of Maternal-Fetal & Neonatal Medicine
The recommendation for elective induction of labor (IOL) is to await ≥ 39 weeks. Studies show earlier maturity of Blacks compared to Whites. The objective was to examine the effect of the Black race on the risk of intrapartum and neonatal complications after IOL. Black women with non-indicated IOL at 37-42 weeks were selected from the CDC-Birth Cohorts 2007-2010. Congenital anomalies, hypertension/diabetes, low-birth weight, breech presentation, previous cesarean and premature rupture of membranes were excluded. Intrapartum/neonatal complications were analyzed. Logistic regression was used to calculate adjusted odds ratios, using 39 weeks as reference. 311,264 black were compared with 2,451,774 deliveries of other races. For Blacks, the risks of cesarean delivery and intrapartum complications were lower at 38 weeks. Chance of vaginal delivery was greater at 38 weeks. Risks of neonatal complications was not increased at 38 compared to 39 weeks. Intrapartum complications were lower at 38 than at 39 weeks in Blacks with no increased risk of neonatal complications. Meconium staining and fetal distress were higher as early as at 40 weeks, perhaps due to accelerated maturation. While a 39-week goal is simple and benefits many patients, a more "personalized medicine" approach may benefit even more mothers and babies.
11 February 2017 in Journal of Obstetrics and Gynaecology Research
1 February 2023 in CIENCIAMATRIA
El objetivo general de la investigación consistió en determinar la relación entre anemia y parasitosis intestinal con el rendimiento académico en escolares del distrito de San Juan de Lurigancho 2022. La investigación fue de diseño no experimental y nivel correlacional; realizó en el ámbito geográfico que comprende el distrito de San Juan de Lurigancho, en niños de 3 a 5 años de centros educativos de inicial, Los resultados reflejaron que la parasitosis intestinal, se encontró una prevalencia de 16.9% con el examen directo de heces. La baja frecuencia de parasitosis hallada en esta investigación, indican una predisposición a las enteroparasitosis, probablemente debido a una adecuada higiene ambiental y condiciones socioeconómicas. Como conclusión se obtuvo que no hay correlación entre anemia, parasitosis y rendimiento académico. Según la prueba chi cuadrado indica que no hay relación entre anemia y rendimiento ni como factor asociado al rendimiento académico (OR= 0.731, no significativo).